Proteins with diagnostic and therapeutic uses
AssigneeThe University Court of the University of Edinburgh
InventorsPaul Barlow, Andrew Herbert, Elisavet Makou
Life of this patent
Estimating the term…
Abstract
A method of treating one or more medical complications associated with aberrant complement regulatory activity in a subject includes the steps of: providing a pharmaceutical composition comprising a recombinant protein capable of binding to complement factor H (CFH) and inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH; and administering to a subject an effective amount of the pharmaceutical composition.
Claims19
A method of treating one or more medical complications associated with aberrant complement regulatory activity in a subject, comprising the steps of:
- providing a pharmaceutical composition comprising a recombinant protein capable of binding to complement factor H (CFH) and inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH;
- and
- administering to a subject an effective amount of the pharmaceutical composition.
Dependencies are inferred from the claim text.